全球丝绸之路研究联盟标志:一道流动的青蓝色波浪

Global Silk Route Research Alliance

全球丝绸之路研究联盟

独立智库 · 地缘政治 · 一带一路 · 欧亚

最新

Citi Pharma submits offer for pharma company acquisition

作者 Prof. Engr. Zamir Ahmed Awan 1 分钟阅读

新闻台署名 来源:新华社、《黎明报》、《阿拉伯新闻》、阿纳多卢通讯社与《分钟镜报》。由 GSRRA 编辑部翻译并节选。

Citi Pharma submits offer for pharma company acquisition
Citi Pharma submits offer for pharma company acquisition

Citi Pharma Limited (PSX: CPHL) has submitted a Non-Binding Offer for the potential acquisition of a leading pharmaceuticals company in Pakistan.

The submission is part of the company’s ongoing strategic expansion plans to become one of the largest players in the pharma industry of Pakistan.

Any further developments will be subject to the outcome of the due diligence process and subsequent approval(s) by the Board of Directors and relevant regulatory authorities.

The aforementioned information was disseminated through a notification to Exchange.

The Company remains committed to keeping the Exchange and shareholders informed of any material developments in this regard.

Reference Link:- https://mettisglobal.news/citi-pharma-submits-offer-for-pharma-company-acquisition/

Prof. Engr. Zamir Ahmed Awan
Prof. Engr. Zamir Ahmed Awan 全球丝绸之路研究联盟创始人兼主席

Zamir Ahmed Awan is the founder and Chair of the Global Silk Route Research Alliance, a think tank in Islamabad. He studied engineering at Shanghai University in the 1980s, and years later he went back to China as Pakistan's science counsellor in Beijing, from 2010 until 2016, working on science and higher education cooperation between the two countries.…

该作者的全部文章

成员与合作伙伴 · 伙伴联盟